The UCSF School of Medicine is ranked No. 1 for the percentage of Hispanic graduate students attending the top-ranked medical school, according to Hispanic Business magazine.

Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.

UCSF research-doctorate programs have ranked among the nation’s best in a survey released today by the National Research Council (NRC).

Researchers at UCSF have been awarded a grant from the National Institutes of Health to develop a rapid, pan-viral microarray diagnostic for detecting viruses of extreme outbreak and pandemic potential.

Genentech scientist Napoleone Ferrara, who has just been named the winner of a Lasker Award, is being recognized for his noteworthy achievements made when he was a postdoc at UCSF.

Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.

Renown Institute for Cancer in Reno and the UCSF Helen Diller Family Comprehensive Cancer Center, the two leading cancer programs in their regions, have joined forces to enhance patient care and improve access to top level medical experts.

Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.

The U.S. Department of Justice declined to consent to the University of California’s motion to intervene in Sherley v. Sebelius, the case regarding federal funding for human embryonic stem cell (hESC) research, on which UC had made a motion to the U.S. Federal Court of Appeals on Sept. 20.